Jeffrey Mathiesen's Trading History
| NMTCNeuroOne Medical Technologies | Apr 07, 2026 | Director | Uninformative Buy | ― | $144.93K | |
| HSDTSolana Company | Feb 18, 2022 | CFO & Treasurer, Director | Uninformative Buy | ― | $24.97K | |
| PBLAPanbela Therapeutics | May 27, 2021 | Director | Uninformative Buy | ― | $112.10 | |
| NUWENuwellis | Jan 02, 2015 | CFO | Uninformative Sell | 4.04K | $278.88K | |
| HCTIHealthcare Triangle | ― | Director | ― | ― | ||
| MTVAMetaVia | ― | Chief Financial Officer | ― | ― |
You May Also Like
Jeffrey Mathiesen insider profile FAQ
What is the percentage of profitable transactions made by Jeffrey Mathiesen?
The percentage of profitable transactions made by Jeffrey Mathiesen is 0%.
What is the average return per transaction made by Jeffrey Mathiesen?
The average return per transaction made by Jeffrey Mathiesen is -64.10%.
What stocks does Jeffrey Mathiesen hold?
Jeffrey Mathiesen holds: NMTC, NUWE, HSDT, MTVA, PBLA, HCTI stocks.
What was Jeffrey Mathiesen's most profitable transaction?
Jeffrey Mathiesen’s most profitable transaction was an Informative Buy of NUWE stock on March 17, 2014. The return on the trade was -33.10%.
What is Jeffrey Mathiesen's role in NeuroOne Medical Technologies?
Jeffrey Mathiesen's role in NeuroOne Medical Technologies is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.